MASIMO CORP (MASI) Stock News
NASDAQ:MASI - Nasdaq - US5747951003 - Common Stock - Currency: USD
MASI Latest News, Press Relases and Analysis
Goldman Sachs Upgrades Cummins (CMI) Stock to Buy, Raises PT
On May 27, analysts at Goldman Sachs upped Cummins Inc. (NYSE:CMI)’s stock from “Neutral” to “Buy,” raising its price objective to $431 from the prior target of $410. This upgrade stems from the expectations of structurally higher profitability in the company’s Power Systems business, thanks to the new pricing structure extending beyond data centers. The […]
Masimo to Present in the Jefferies Global Healthcare Conference
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Do You Believe in the growth potential of Masimo Corporation (MASI)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]
Kilroy reports lackluster earnings as West Coast tenants downsize
Kilroy Realty’s Angela Aman with 384 Oyster Point Boulevard (Edward Carreon, Google Maps, Getty)Kilroy Realty’s earnings last quarter were fair to middling as office and life sciences occupancy slackened further across its 17.1-million-square-foot portfolio in San Francisco, Los Angeles, Seattle and San Diego, the company reported Tuesday. Kilroy’s funds from operations were $122.3 million, or $1.02 per diluted share in […]This article originally appeared on The Real Deal. Click here to read the
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised
COR's second-quarter fiscal 2025 results showcase a strong segmental performance. The company's earnings guidance for fiscal 2025 looks encouraging.
MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand
Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties.
Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up
OMCL posts better-than-expected top and bottom-line results for the first quarter of 2025.
Masimo to Present in the BofA Securities 2025 Health Care Conference
Masimo to divest consumer audio division to Samsung’s Harman
The decision to sell follows Masimo’s strategic review of its consumer audio operations.
Mentions: MS
Why Constellation Energy Corporation (CEG) Skyrocketed On Tuesday
We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to take a look at where Constellation Energy Corporation (NASDAQ:CEG) stands against other Tuesday’s best-performing stocks. The stock market ended the trading session in the red on Tuesday, with all major indices giving up earlier gains, […]
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates
Masimo (MASI) delivered earnings and revenue surprises of 9.68% and 1.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: LIVN
Masimo to Sell Consumer Audio Business to HARMAN International
Masimo Reports First Quarter 2025 Results
NVST Stock Up on Q1 Earnings and Revenue Beat, Margins Crash
Envista delivers better-than-expected top and bottom-line results for the first quarter of 2025.
ZBH Q1 Earnings Beat, Operating Margin Dips, Stock Down in Premarket
Zimmer Biomet reports solid first-quarter performance across its geographic regions. However, contraction in its operating margin is a concern.
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up
Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket
Bio-Rad witnesses first-quarter top-line decline in its Life Science segment, primarily due to challenges in the academic research market.
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline
Glaukos' first-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains
Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market
IDEXX delivers year-over-year earnings and revenue growth in the first quarter of 2025.
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
CNMD reports solid first-quarter results, driven by improving sales across both segments.
ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates
Ecolab's robust performance across the majority of its segments drives its first-quarter organic sales despite business challenges.